中轴型脊柱关节炎患者血小板中Dkk-1表达下调
结果显示患者血清Dkk-1浓度显著降低,血小板Dkk-1在转录和蛋白水平均显著下调,提示巨核细胞/血小板轴功能障碍可能参与中轴型SpA新骨形成。
要点
- 中轴型SpA患者血清Dkk-1浓度较健康对照显著降低(P < 0.0001)。
- 患者血小板DKK1 mRNA(P < 0.04)和Dkk-1蛋白(P < 0.007)表达均显著降低。
- 血小板来源Dkk-1下调可能参与中轴型SpA新骨形成机制。
核心结论
- 中轴型SpA患者血清Dkk-1水平降低,且血小板Dkk-1在转录和蛋白水平均下调,巨核细胞/血小板轴功能障碍可能是血清Dkk-1降低的原因,并可能参与新骨形成。
研究设计与样本
- 血小板DKK1 mRNA采用定量逆转录聚合酶链反应分析20例患者和20名对照,Dkk-1蛋白采用免疫印迹法测定20例患者和18名对照。
主要发现
- 中轴型SpA患者血清Dkk-1浓度低于健康对照(P < 0.0001)。
- 患者血小板Dkk-1转录水平显著降低(P < 0.04)。
- 患者血小板Dkk-1蛋白水平显著降低(P < 0.007)。
临床怎么用
- 血清Dkk-1及血小板Dkk-1表达可能作为反映中轴型SpA Wnt通路异常和新骨形成的候选生物标志物,但尚需进一步验证。
局限性
- 作者称其为初步观察,血小板DKK1 mRNA和蛋白检测的样本量分别仅为20对和20例对18名对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Axial spondyloarthritis (SpA) is a chronic autoinflammatory disease with new bone formation, which is controlled by Wnt/β-catenin signaling. Dkk-1 is an inhibitor of the Wnt pathway, and in humans, platelets represent a major source of Dkk-1. This study was undertaken to investigate whether levels of Dkk-1 in serum and platelet expression of DKK1 messenger RNA (mRNA) and Dkk-1 protein are affected in patients with axial SpA compared to healthy controls. METHODS: Forty-one patients with axial SpA and 35 healthy controls were enrolled in the study. Total serum Dkk-1 levels in all patients and healthy controls were measured by quantitative enzyme-linked immunosorbent assay. Platelet DKK1 mRNA was analyzed by quantitative reverse transcriptase-polymerase chain reaction in 20 patients with axial SpA and 20 controls, and Dkk-1 protein levels were measured by immunoblotting in 20 patients with axial SpA and 18 controls. RESULTS: We found a lower concentration of Dkk-1 in the serum from patients with axial SpA compared to the serum from healthy controls (P < 0.0001). Furthermore, the expression of Dkk-1 was significantly reduced both at the transcriptional level (P < 0.04) and at the protein level (P < 0.007) in platelets isolated from the blood of patients with axial SpA. CONCLUSION: Our preliminary observations suggest that dysfunction of the megakaryocyte/platelet axis might be responsible for reduced serum Dkk-1 levels in patients with axial SpA. Dkk-1 is down-regulated in the platelets of patients with axial SpA, a mechanism that might play a role in new bone formation.
引用
- Czepiel M, Stec M, Korkosz M, et al. Down-Regulation of Dkk-1 in Platelets of Patients With Axial Spondyloarthritis. Arthritis Rheumatol. 2021. PMID: 33779048. doi:10.1002/art.41739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。